NCI logo

 DCTD: BIOMETRIC RESEARCH PROGRAM


Drug Discovery and Pre-Clinical Development


BRP staff provide statistical leadership for the pre-clinical drug discovery and development activities of the Division of Cancer Treatment and Diagnosis. Staff collaborates in the design and implementation of analytic tools to predict clinical activity against a molecular target based on in-vivo models and in-vitro tumor cell line screens. Staff collaborate in the design and analysis of early clinical trials of new anti-cancer therapies, with particular focus on the measurement of biologic effects associated with molecular targets. BRP staff also conduct research to develop more effective designs for pre-clinical studies and early clinical trials and provides advice to professional staff both within and outside of the NCI on the design and analysis of such studies.



Please send comments and suggestions to mailto logobrb@brb.nci.nih.gov

Updated on Nov. 2, 2015